ImageneBio, Inc. SEC filings IMA
ImageneBio, Inc. has 336 filings in SEC EDGAR's recent list, going back to Jan 8, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| S-3 | Shelf registration | Aug 5, 2026 | — |
| POS AM | Filing | Aug 5, 2026 | — |
| 424B3 | Prospectus | Aug 5, 2026 | — |
| S-3 | Shelf registration | Aug 5, 2026 | — |
| 424B3 | Prospectus | Jul 23, 2026 | — |
| 424B3 | Prospectus | Jun 29, 2026 | — |
| 424B3 | Prospectus | Jun 17, 2026 | — |
| 424B3 | Prospectus | May 8, 2026 | — |
| 424B3 | Prospectus | May 7, 2026 | — |
| 424B3 | Prospectus | Apr 13, 2026 | — |
| POS AM | Filing | Apr 2, 2026 | — |
| S-8 | Employee stock plan registration | Mar 10, 2026 | — |
| 424B3 | Prospectus | Feb 17, 2026 | — |
| 424B3 | Prospectus | Dec 18, 2025 | — |
| S-8 | Employee stock plan registration | Nov 12, 2025 | — |
| 424B3 | Prospectus | Nov 12, 2025 | — |
| 424B3 | Prospectus | Nov 5, 2025 | — |
| 424B3 | Prospectus | Oct 30, 2025 | — |
| S-1 | Registration statement | Sep 8, 2025 | — |
| 424B3 | Prospectus | Jun 11, 2025 | — |
| S-4/A | Filing | Jun 9, 2025 | — |
| S-4/A | Filing | May 30, 2025 | — |
| S-4/A | Filing | May 20, 2025 | — |
| S-4/A | Filing | May 7, 2025 | — |
| S-4/A | Filing | Apr 21, 2025 | — |
| S-4 | Registration for a merger or exchange | Mar 18, 2025 | — |
| S-8 | Employee stock plan registration | Mar 12, 2024 | — |
| 424B5 | Prospectus supplement | Sep 12, 2023 | — |
| S-3 | Shelf registration | Aug 18, 2023 | — |
| 424B5 | Prospectus supplement | May 15, 2023 | — |
| S-8 | Employee stock plan registration | Mar 14, 2023 | — |
| S-3 | Shelf registration | Apr 27, 2022 | — |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| S-8 | Employee stock plan registration | Mar 30, 2021 | — |
| 424B4 | Prospectus | Mar 26, 2021 | — |
| S-1/A | Amended registration statement | Mar 22, 2021 | — |
| S-1 | Registration statement | Mar 5, 2021 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IMA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1835579
- Former names
- Ikena Oncology, Inc. (until Jul 25, 2025)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.